
Fountain Therapeutics develops treatments for aging-associated diseases.
Fountain Therapeutics, founded with the mission to develop treatments for aging-associated diseases, focuses on restoring cellular resilience to combat degenerative conditions. By leveraging a deep understanding of cellular aging pathways, the company aims to address the root causes of various physiological deteriorations. Their innovative platform targets the biological processes that underlie many age-related diseases, offering potential therapeutic solutions to improve healthspan and quality of life.
Notably, Fountain Therapeutics was co-founded by Thomas Rando, M.D., Ph.D., who serves as the Executive Chairman and has been recognized with the prestigious NOMIS Distinguished Scientist Award. The company has made significant strides in the biotechnology sector, contributing to the broader understanding and treatment of age-related diseases. Their pioneering work has positioned them as a key player in the field of regenerative medicine, with a growing impact on both scientific research and potential clinical applications.

Retro Biosciences
retro.bio

Fountain Life
fountainlife.com

Deciduous Therapeutics
deciduoustx.com

Dorian therapeutics

Gerostate Alpha

AgeX Therapeutics

Rejuveron Life Sciences
rejuveron.com

Longeveron
longeveron.com

ProFound Therapeutics
profoundtx.com

Fount Bio
fountbio.com

Amplifier Therapeutics
amplifier-tx.com

Tranquis Therapeutics
tranquis.com

Samsara Therapeutics

Stemson Therapeutics
stemsontx.com

Repair Biotechnologies
Companies similar to Fountain Therapeutics include Retro Biosciences, Fountain Life, Deciduous Therapeutics and Dorian therapeutics.
Fountain Therapeutics was founded in 2018.
Fountain Therapeutics' headquarters is located in Stanford, CA, US.
Fountain Therapeutics' most recent funding round was for $15M (USD) in November 2021.
As of Nov 18, 2021, Fountain Therapeutics has raised a total of $26M (USD).
Fountain Therapeutics has 37 employees as of Feb 5, 2024.